
PharmaBlock Inaugurates its New OPC R&D Center in Nanjing, China
PharmaBlock Sciences officially inaugurated its new OPC (Oligonucleotides, Peptides, and Conjugates) R&D Center in Nanjing, China.

PharmaBlock Sciences officially inaugurated its new OPC (Oligonucleotides, Peptides, and Conjugates) R&D Center in Nanjing, China.

How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.